Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Operational Other
confidence 72%
filed 2026-07-16
The filing discloses an operational update on Eightco's treasury holdings and strategic positioning across three mega-trends (AI, digital identity, creator economy), with specific valuations of holdings in OpenAI ($90M), Beast Industries ($18M), Worldcoin tokens (283M WLD), and cash ($148M), totaling ~$406M. While framed as a Regulation FD disclosure (Item 7.01), the substance is a material operational and strategic update regarding the company's portfolio composition and market positioning, not a routine administrative matter. This does not fit earnings_release (no financial results), ma_activity (no transaction), or other specific categories, making operational_other the most appropriate classification.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 92%
filed 2026-07-16
Green Circle entered into a securities purchase agreement on July 16, 2026, to issue unsecured promissory notes (US$10M principal, US$8M subscription price) and common warrants exercisable for up to 29.1 million ordinary shares at US$2.00 per share. The offering is exempt from Securities Act registration and represents a significant dilutive issuance of equity warrants and convertible debt instruments to raise capital.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 95%
filed 2026-07-16
Item 3.01 discloses that SRX Global has regained compliance with NYSE American listing standards after resolving deficiencies under Section 1003(a)(i) and (ii) of the Company Guide that were previously cited in an October 14, 2025 notice. The removal of the compliance indicator (".BC") and delisting risk is material to investors assessing the registrant's continued trading status and financial viability.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-07-16
The filing discloses Palomino Laboratories' entry into a binding letter of intent to acquire all outstanding shares of Vega Links Inc. in an all-stock transaction (4,472,000 shares at a 1:2.5 exchange ratio). Item 1.01 explicitly covers "Entry into a Material Definitive Agreement," and the press release emphasizes this as a transformative transaction that expands the addressable market by 10x (from $6B to $60B) and combines complementary AI interconnect technologies. This is a material acquisition activity subject to due diligence and definitive agreement execution.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-07-16
This 8-K Item 5.07 discloses the results of a Special Meeting of Stockholders held on July 15, 2026, with voting results on seven proposals. The filing reports final vote tallies from the Inspector of Elections for each proposal, including approval of warrant issuances exceeding 19.99% of outstanding shares (Proposals 1-5), authorization for a reverse stock split (Proposal 6), and meeting adjournment authority (Proposal 7). All proposals were approved. The warrant issuances and reverse split authorization are material capital structure events requiring shareholder approval under NYSE American rules.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-16
The filing discloses the election of Benjamin Buchanan as an independent director effective July 15, 2026, with appointment to the Audit Committee, Compensation Committee, and Nomination and Governance Committee. The appointment is material because it restores the Audit Committee to three members and brings the Company into compliance with Nasdaq Listing Rules 5605(c)(2)(A) and 5605(b), addressing prior governance deficiencies.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-07-16
The filing discloses two board appointments on July 15, 2026: Guibao Ji (the Company's CFO) and Alejandro Quiles, with Quiles designated as Compensation Committee chairman and determined to be independent under Nasdaq Rule 5605(a)(2). While the filing also mentions Chenlong Liu's resignation on July 10, the principal disclosed action centers on the two new director appointments and their committee assignments, making exec_appointment the most salient classification. The appointments are material to investors as they affect board composition and governance structure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-16
The filing discloses that on July 15, 2026, the board of directors appointed Michael Regan as Chief Operating Officer and Secretary of SHF Holdings, Inc. This is a clear executive appointment to a material officer position. The disclosure is made under Item 5.02, which covers both departures and appointments, and the principal action disclosed is the appointment of an officer to a senior operational role.
View raw filing on EDGAR →
6-K
M&A activity
confidence 92%
filed 2026-07-16
On July 13, 2026, Forafric Agro Industries Limited (a subsidiary of Forafric Global PLC) entered into a Share and Credit Purchase Agreement to sell 100% of the share capital of Forafric Portugal to Mr. Farid Rehmani for US$1,400,000. This is a material disposition of a subsidiary as part of the company's stated restructuring plan, with closing expected by November 3, 2026, subject to customary conditions precedent.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-07-16
The filing discloses an Amendment to a Merger Agreement dated July 16, 2026, among JFB Construction Holdings, Xtend AI Robotics, Inc., and related entities. The Amendment modifies material terms of a previously disclosed merger transaction, including shortening timelines for consideration schedules, adjusting closing cash thresholds from $110M to $60M, extending the outside closing date to October 31, 2026, and adding lock-up and transfer restrictions. This constitutes a material amendment to an entry into a material definitive agreement under Item 1.01, representing a significant M&A activity disclosure that would materially affect investor assessment of the registrant's strategic direction and transaction terms.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 95%
filed 2026-07-16
ZyVersa Therapeutics ceased trading on the OTCQB Venture Market and moved to the OTC Pink Limited Market effective July 16, 2026. This represents a downgrade in listing status and is a material transfer of listing that signals potential delisting risk or failure to maintain continued listing standards. The move from OTCQB to OTC Pink is a significant negative development for investor visibility and liquidity.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 98%
filed 2026-07-16
Our Bond, Inc. received notification from Nasdaq on July 14, 2026 that it has failed to maintain compliance with three critical listing standards: minimum bid price of $1.00 per share, minimum market value of publicly held shares of $15 million, and minimum market value of listed securities of $50 million. The company has been granted 180 calendar days (until January 11, 2027) to regain compliance, and Nasdaq will publicly list the company as non-compliant on its website. This is a classic delisting-risk disclosure under Item 3.01.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-07-16
The filing discloses a private investment in public equity (PIPE) on July 10, 2026, involving the issuance of 443.2133 shares of Series A Convertible Preferred Stock (convertible into common stock at $0.40/share) and 1,052,632 warrants to acquire common stock at $0.40/share, for aggregate proceeds of $400,000. Items 1.01 and 3.02 explicitly document the unregistered sale of equity securities under Section 4(a)(2) exemption. This is a classic dilutive issuance typical of small-cap companies raising capital through convertible securities and warrants.
View raw filing on EDGAR →
8-K
Auditor Change
confidence 95%
filed 2026-07-16
The filing discloses the dismissal of TAAD LLP as the Company's independent registered public accounting firm on July 13, 2026, and the engagement of Green Growth CPAs as the new auditor on July 16, 2026. Item 4.01 explicitly addresses "Changes In Registrant's Certifying Accountant." The materiality is heightened by the fact that the former auditor's reports contained an explanatory paragraph noting substantial doubt about the Company's ability to continue as a going concern, making the auditor change particularly significant to investors.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 75%
filed 2026-07-16
The filing discloses establishment of Series A Convertible Preferred Stock with 25,000 shares reserved for issuance, convertible into common stock at a market-based conversion price (90% of lowest VWAP). Although no shares have yet been issued, the creation of this convertible security structure with substantial dilutive potential (conversion tied to common stock issuance exceeding 20% of outstanding shares) represents a material capital structure change and potential dilutive issuance framework. This is disclosed under Item 5.03 (Articles/Bylaws amendment) but the substance is a dilutive financing instrument.
View raw filing on EDGAR →
8-K
Exec departure
confidence 75%
filed 2026-07-16
The filing discloses the departure of Lance Alstodt (President, CEO, and Chairman) and Robert Kristal (CFO) on July 13, 2026, both asserting "Good Reason" resignations tied to a claimed Change in Control. While the Board disputes the validity of these claims and has reserved all rights, the departures of the CEO and CFO are material events that would affect a reasonable investor's assessment of the registrant. The filing also includes amendments to executive employment agreements narrowing Change in Control triggers and the appointment of interim leadership, but the principal disclosed action centers on the departure of two key executives.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-07-16
The filing discloses entry into a new lease agreement (Item 1.01) and termination of an existing lease (Item 1.02), with an estimated annual savings of $1.1 million in rent and facility-related expenses. While this involves material definitive agreements, it is primarily an operational/real estate transaction rather than a financial obligation in the traditional sense (debt issuance, covenant breach, etc.). The company is relocating to more cost-efficient premises, which is a strategic operational decision material to investors assessing the registrant's cost structure and operational efficiency.
View raw filing on EDGAR →
8-K
Governance Other
confidence 75%
filed 2026-07-16
The filing discloses a correction of prior disclosure regarding the effectiveness of an authorized share decrease (from 27.5 billion to 12 billion shares). The Company inadvertently reported in its 10-K and 10-Q that the Certificate of Amendment had been filed and accepted when it had not yet been filed with the Nevada Secretary of State. The Certificate was actually accepted on July 15, 2026. While the Company states this was unintentional and administrative, and does not constitute a restatement under Item 4.02, the disclosure of material inaccuracies in previously filed periodic reports regarding authorized capitalization is a governance matter affecting the accuracy of corporate records and shareholder communications.
View raw filing on EDGAR →
6-K
Delisting risk
confidence 98%
filed 2026-07-16
EX-99.1
Pitanium Limited received a delisting determination letter from Nasdaq dated July 7, 2026, notifying the Company that Nasdaq Staff has determined to delist the Company's securities from Nasdaq pursuant to Listing Rule IM-5101-4. Trading suspension is scheduled for July 16, 2026, unless the Company appeals by July 14, 2026. This is a definitive delisting notice, not merely a risk or warning, making it a material event that directly affects the registrant's continued listing status and investor access to trading.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-07-16
Item 2.02
FingerMotion issued a news release on July 16, 2026 reporting Q1 fiscal 2027 financial results for the period ended May 31, 2026, disclosing quarterly revenue of $650,089 (down 92% year-over-year), gross profit, operating expenses, net loss of $2.00 million, EPS, and balance sheet metrics.
View raw filing on EDGAR →
6-K
Dividend Distribution
confidence 95%
filed 2026-07-16
EX-99.1
The press release announces the declaration of quarterly dividends on eight series of preferred shares by Pembina's Board of Directors, specifying dividend amounts per share and payment/record dates. This is a routine but material capital distribution to shareholders. The document also announces the timing of the Q2 2026 earnings release and conference call, but the primary disclosed action is the dividend declaration.
View raw filing on EDGAR →
8-K
M&A activity
confidence 97%
filed 2026-07-16
Item 1.01
Uber entered into a Business Combination Agreement on July 16, 2026, to acquire Delivery Hero through a voluntary public takeover offer at €41.50 per share, representing an equity value of €14.8 billion ($14.8 billion). The transaction will expand Uber's delivery platform to 99 markets with combined pro-forma Gross Bookings of $236 billion, funded through existing cash and a committed €14.2 billion bridge credit facility, with expected closing in H2 2027 subject to regulatory approvals and a 50%+ acceptance threshold.
View raw filing on EDGAR →
6-K
Earnings release
confidence 95%
filed 2026-07-16
EX-99.1
This exhibit is a press release announcing Sify Technologies' consolidated financial results for Q1 FY 2026-27, disclosing revenues of INR 12,352 Million (15% YoY growth), Adjusted EBITDA of INR 3,005 Million (42% YoY growth), and profit of INR 65 Million. The document includes detailed unaudited consolidated income statements, segment reporting, and management commentary on operational performance—all hallmarks of a quarterly earnings release. Material to investors assessing the registrant's financial performance and operational trajectory.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 85%
filed 2026-07-16
Item 8.01
News Corporation discloses daily share repurchase activity under its authorized $1 billion repurchase program, with specific transactions totaling approximately $240.2 million across Class A and Class B common stock. Share repurchases are a form of capital return to shareholders and fall within the dividend_distribution category, which encompasses share-repurchase programs. The exhibits show actual buyback execution with prices paid and volumes repurchased, demonstrating material capital deployment.
View raw filing on EDGAR →
8-K
M&A activity
confidence 97%
filed 2026-07-16
Item 1.01
Braemar Hotels & Resorts entered into an Agreement of Purchase and Sale on July 13, 2026, to sell the Pier House Resort & Spa in Key West, Florida for $190.0 million in cash, and completed the sale of three other hotel properties (The Ritz-Carlton Sarasota, Hotel Yountville, and Bardessono Hotel) for approximately $437.5 million on July 14, 2026. These material dispositions generated approximately $158.2 million in pre-tax gains and significantly reduced the company's asset base while enabling substantial debt repayment of $232.8 million.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-07-16
Item 5.07
This Item 5.07 disclosure reports the final voting results from Advanced Drainage Systems' 2026 Annual Meeting of Stockholders held on July 16, 2026. The filing presents detailed tabulations for three proposals: election of nine directors, ratification of Deloitte & Touche LLP as independent auditor, and advisory approval of executive compensation. All three proposals passed with substantial majorities. This is a classic shareholder vote results disclosure required under Item 5.07 of Form 8-K.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-07-16
Item 5.02
The filing discloses that Hayden Brown, the Company's President and CEO, has been appointed to assume the role of interim principal financial officer effective July 14, 2026, during CFO Erica Gessert's temporary medical leave. While the departure of the CFO is also mentioned, the principal disclosed action is the appointment of Brown to the interim CFO role. This is material because it involves a change in the principal financial officer position, a key executive role affecting investor confidence in financial reporting and governance.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-07-16
Item 5.02
The disclosure centers on a performance-based restricted stock unit (PSU) award granted to CEO Sridhar Ramaswamy on July 15, 2026, consisting of 1,000,000 shares with stock price milestones designed to create up to $100 billion in stockholder value. This is a compensatory arrangement for a named executive officer disclosed under Item 5.02(e), distinct from an appointment or departure. The award's material terms—including vesting conditions, performance periods, and clawback provisions—are detailed, making this a significant executive compensation disclosure material to investors assessing executive incentive alignment and retention strategies.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-16
Item 2.02
Abbott disclosed its second-quarter 2026 financial results on July 16, 2026, including reported sales growth of 13.0%, comparable sales growth of 4.8%, GAAP diluted EPS of $0.53, and adjusted diluted EPS of $1.31. The company also raised its full-year 2026 adjusted diluted EPS guidance range to $5.45–$5.60. This is a standard quarterly earnings release furnished as Exhibit 99.1, filed under Item 2.02 (Results of Operations and Financial Condition).
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-07-16
Item 5.02
The filing discloses the appointment of Bobby L. Owens as General Counsel effective July 13, 2026, with detailed compensation terms including $325,000 base salary, 60% bonus target, $100,000 sign-on equity award, and severance provisions. While the section also mentions Jonathan Norling's termination as Chief Legal Officer, the principal disclosed action centers on the appointment of a new named executive officer with a comprehensive offer letter. The appointment of a General Counsel to lead the company's legal function is material to investors assessing management quality and governance.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-07-16
Item 5.02
The disclosure centers on an updated offer letter for David Vetter as Chief Legal Officer, detailing compensatory arrangements including a $670,000 annual base salary, 100% bonus target, and $1.5 million in equity awards (60% time-based, 40% performance-based). While the filing is under Item 5.02(e), the principal disclosed action is the modification of executive compensation terms, not a departure or appointment, making exec_compensation the most salient classification.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 75%
filed 2026-07-16
Item 8.01
Ryan Steelberg, the President, CEO, and Chairman, voluntarily reduced his salary by 50% from $665,000 to $332,500 effective July 14, 2026. This is a material modification to executive compensation arrangements disclosed under Item 8.01. While the reduction is voluntary and supportive of cost initiatives, it represents a significant change to a named executive's compensation that would affect investor assessment of the company's financial condition and leadership commitment.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-07-16
Item 8.01
This disclosure describes a statutory scheme of arrangement under English law whereby New Gates (a Bermuda exempted company) becomes the parent holding company of the Gates Group through a redomiciliation. Old Gates shareholders will have their shares cancelled and receive equivalent New Gates shares, with trading transitioning from the old to new entity on the NYSE under the same ticker. This constitutes a material change of control and corporate restructuring meeting the definition of ma_activity, though it is technically a redomiciliation rather than a traditional M&A transaction.
View raw filing on EDGAR →
8-K
Cybersecurity Incident
confidence 95%
filed 2026-07-16
Item 8.01
The disclosure describes unauthorized third-party access to fairlife's systems via a ransomware event, resulting in temporary suspension of U.S. production operations. This is a material cybersecurity incident involving a breach of production-related systems and operational disruption, requiring mandatory disclosure under Item 1.05 (or Item 8.01 as here). The incident's materiality is evidenced by the production shutdown and ongoing investigation, despite the company's caveat that full impacts are not yet determined.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-16
Item 5.02
Christopher Peetz was appointed as a new member of the Board of Directors effective July 15, 2026, with the Board increasing authorized directors from nine to ten. Peetz brings extensive biopharmaceutical leadership experience, including his current CEO role at Mirum Pharmaceuticals, and received an initial stock option award of 21,486 shares plus prorated annual equity and cash retainer.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 85%
filed 2026-07-16
Item 7.01
Valero's Board authorized a $5.0 billion share repurchase program on July 16, 2026, in addition to $1.4 billion remaining under a February 2026 program, totaling $6.4 billion in authorized buyback capacity. Share repurchase programs are a form of capital return to shareholders and fall within the dividend_distribution category, which encompasses "share-repurchase programs" alongside dividends and distributions. This is material to investors as it signals capital allocation priorities and affects share count and EPS.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 98%
filed 2026-07-16
Item 3.01
Cycurion received a Staff Determination Letter from Nasdaq on July 10, 2026, notifying the company of delisting due to failure to maintain the $1.00 minimum bid price for 31 consecutive business days. The company is ineligible for the customary 180-day compliance period due to a reverse stock split effected within the prior year, with trading suspension expected July 21, 2026 absent a timely hearing request.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-07-16
Item 5.07
This is a classic Item 5.07 disclosure of shareholder vote results from DOMO's Annual Meeting held July 14, 2026. The filing reports voting outcomes on three proposals: election of eight directors (all elected), ratification of Ernst & Young LLP as independent auditor (ratified), and advisory approval of named executive officer compensation (approved). The high quorum (95.86% of voting power) and detailed vote tallies are characteristic of shareholder_vote_results disclosures.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-07-16
Item 5.01
Kenneth R. Lehman converted 4,000 shares of Preferred Stock into 11,428,000 common shares representing 42.38% of outstanding common stock pursuant to an Exchange Agreement dated April 28, 2026, triggering a material change of control. Lehman obtained the right to designate directors and intends to serve on both the Company's and Bank's Boards.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-07-16
Item 5.07
At a Special Meeting of Shareholders held on July 14, 2026, shareholders approved the issuance of 2,401,615 shares upon conversion of Series D and E preferred stock and an amendment to increase authorized common shares from 15 million to 100 million. These votes reflect material changes to the company's capital structure and dilution profile.
View raw filing on EDGAR →
8-K
Governance Other
confidence 85%
filed 2026-07-16
Item 8.01
The disclosure announces a 1-for-3 reverse stock split of TOMI's common and preferred stock, effective July 20, 2026. This is a governance and capital structure event that affects all shareholders' holdings and the company's trading mechanics (new CUSIP, adjusted exercise prices for options and warrants). While not a named event type, it is clearly a governance matter affecting shareholder rights and the company's equity structure, making it material to investors.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-07-16
Item 2.03
The filing discloses the creation of direct financial obligations through the issuance of consolidated obligation bonds and discount notes by the Federal Home Loan Bank of New York. Schedule A lists specific debt securities with trade dates of 7/13/2026 and 7/14/2026, settlement dates in July 2026, and principal amounts totaling approximately $3.675 billion. This is a classic debt issuance disclosure under Item 2.03, creating new direct financial obligations in the capital markets.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-07-16
Item 3.02
Bio-Path Holdings completed two unregistered sales of common shares under a qualified Tier 1 Regulation A offering on April 30 and May 13, 2026, totaling 955,300 shares and approximately $28,659 in net proceeds, with the capability to raise an additional $571,341 indicating ongoing dilutive financing activity.
View raw filing on EDGAR →
8-K
Governance Other
confidence 75%
filed 2026-07-16
Item 5.03
The company's Board and Control Shareholder approved on July 14, 2026 the creation of a new Series B Preferred stock class with 5 million authorized shares, each convertible into 1,000 common shares, representing a material amendment to the articles of incorporation with significant potential dilution to common shareholders.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-07-16
Item 2.02
iQSTEL Inc announced preliminary net revenue of approximately $207 million for the first six months of 2026, representing 59% year-over-year growth compared to the same period in 2025.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-07-16
Item 8.01
The company completed the creation of IQSTEL Operating Holdings Inc., a wholly owned subsidiary effective July 2, 2026, as a material internal corporate restructuring designed to enhance financial transparency, improve access to financing, and simplify future M&A activity.
View raw filing on EDGAR →
6-K
Governance Other
confidence 85%
filed 2026-07-16
EX-99.1
This is a notification of a relevant change to a significant shareholder under AIM Rules. BlackRock, Inc. crossed a 5% threshold on July 14, 2026, holding 6.18% of voting rights (1,196,365 votes) through direct shares (5.00%), securities lending (0.78%), and CFDs (0.39%). While not a traditional governance event like an executive appointment or board change, this disclosure of a major shareholder crossing a regulatory threshold is material to investors as it affects the control structure and voting dynamics of the company.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 75%
filed 2026-07-16
Item 5.02
The disclosure centers on an amendment to a Director Services Agreement with William P. Foley II that modifies his compensatory arrangement by deleting a provision permitting him to sell 50% of his shares back to Cannae at defined prices. This is a material modification to an executive's equity-related compensation arrangement, triggered by the closing of the Brasada Ranch sale. While the transaction itself is M&A-related, the Item 5.02 disclosure focuses on the compensatory arrangement amendment rather than the sale itself.
View raw filing on EDGAR →
8-K
Material Litigation
confidence 78%
filed 2026-07-16
Item 1.01
Sadot Group Inc. settled a material lawsuit (Helena Global Investment Opportunities I Ltd. v. Sadot Group Inc., Case No. 1:26-cv-05818) involving alleged breaches of financing agreements and claims for liquidated damages. Under the Settlement Agreement, the Company agreed to pay $350,000 in cash and terminate its $10,000,000 equity line of credit facility with Helena.
View raw filing on EDGAR →
8-K
Governance Other
confidence 85%
filed 2026-07-16
Item 5.03
The filing discloses a one-for-four reverse stock split effected via Certificate of Change filed with Nevada Secretary of State, reducing authorized shares from 400 million to 100 million and changing the CUSIP number. While this is a structural capital event, it is primarily a governance/corporate action matter (Item 5.03) rather than a financial obligation or operational event. The concurrent NYSE American trading halt due to sub-$0.10 pricing and delisting risk is material context, but the core disclosure is the reverse split itself—a governance restructuring that would affect a reasonable investor's assessment of share structure and listing status.
View raw filing on EDGAR →